Efficacy and Safety of Sublingual Melatonin in alleviation of irratable Bowel
Phase 3
Recruiting
- Conditions
- Irritable Bowel Syndrom.Irritable bowel syndrome
- Registration Number
- IRCT20121021011192N14
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Patients above 18 years old with compliant of lower abdominal pain and changes in defecation more than three months
obtaining consent form for entry the study
Exclusion Criteria
Pregnant or breastfeeding women
Patients with Kidney injury (AKIN classification stage 3)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score of quality of life on the basis of IBS-QOL34. Timepoint: Before intervention and 4 weeks after initiation of use of melatonin. Method of measurement: QOL34 questionarre.
- Secondary Outcome Measures
Name Time Method